We have located links that may give you full text access.
Journal Article
Meta-Analysis
Review
Systematic Review
Usefulness of CHADS 2 score for prognostic stratification of patients with coronary artery disease: A systematic review and meta-analysis of cohort studies.
International Journal of Cardiology 2017 Februrary 2
OBJECTIVE: To evaluate the role of CHADS2 score on predicting ischaemic stroke or transient ischaemic attack (TIA) and death in patients with coronary artery disease (CAD), irrespective of the presence or absence of atrial fibrillation (AF).
METHODS: We searched for cohort studies that reported risk estimates for incidence of ischaemic stroke/TIA or mortality by levels of CHADS2 score in Medline/PubMed and Embase. Random effects models were used to calculate pooled risk ratios (RRs) and 95% confidence intervals (CIs).
RESULTS: Eight cohort studies (7 prospective and 1 retrospective) enrolling 31,509 patients with CAD were included. The pooled RR of mortality was 2.38 (95% CI 1.63-3.47) for CHADS2 score≥2, and of stroke/TIA incidence was 2.19 (1.55-3.08). In patients without AF, CHADS2 score≥2 was associated with increased mortality (pooled RR 3.14 95% CI 2.14-4.61) and stroke/TIA incidence (pooled 2.81, 2.08-3.78) In patients with AF, the pooled RR of mortality for CHADS2 score≥2 was 1.57 (1.07-2.28), but no significant association was found between CHADS2 score and stroke/TIA incidence (pooled RR 1.21, 95% CI 0.84-1.73).
CONCLUSIONS: CHADS2 score can predict mortality in patients with CAD. However, higher CHADS2 score is associated with increased incidence of stroke/TIA only in patients without AF.
METHODS: We searched for cohort studies that reported risk estimates for incidence of ischaemic stroke/TIA or mortality by levels of CHADS2 score in Medline/PubMed and Embase. Random effects models were used to calculate pooled risk ratios (RRs) and 95% confidence intervals (CIs).
RESULTS: Eight cohort studies (7 prospective and 1 retrospective) enrolling 31,509 patients with CAD were included. The pooled RR of mortality was 2.38 (95% CI 1.63-3.47) for CHADS2 score≥2, and of stroke/TIA incidence was 2.19 (1.55-3.08). In patients without AF, CHADS2 score≥2 was associated with increased mortality (pooled RR 3.14 95% CI 2.14-4.61) and stroke/TIA incidence (pooled 2.81, 2.08-3.78) In patients with AF, the pooled RR of mortality for CHADS2 score≥2 was 1.57 (1.07-2.28), but no significant association was found between CHADS2 score and stroke/TIA incidence (pooled RR 1.21, 95% CI 0.84-1.73).
CONCLUSIONS: CHADS2 score can predict mortality in patients with CAD. However, higher CHADS2 score is associated with increased incidence of stroke/TIA only in patients without AF.
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app